# Orakl Oncology funding rounds and investors

As of 13 Nov 2026, Orakl Oncology has raised $33.4M across 1 verified round on record (amounts in other currencies converted to USD), plus 1 round still being checked; latest: €30 million ($34 million) Series A led by Norrsken VC and Singular, announced 12 Nov 2026.

A French TechBio company using AI and real patient biology to predict how cancer drugs will perform in clinical trials

Website: https://www.orakl-oncology.com/  
Headquarters: France  
Page: https://fireround.dev/companies/orakl-oncology.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-11-12 | Series A | €30 million ($34 million) | Norrsken VC, Singular | Dorothy Chou, HCVC, Infravia, Jacques Boitreaud, Mostafa Elsayed, Patient Autonome Fund managed by Bpifrance, Plug and Play, Serena Ventures, Speedinvest, Stanislas Polu, Teampact Ventures, Thomas Wolf, Verve Ventures | [eu-startups.com](https://www.eu-startups.com/2026/11/can-ai-predict-which-cancer-drugs-will-actually-work-orakl-oncology-raises-e30-million-to-find-out), [techfundingnews.com](https://techfundingnews.com/paris-based-orakl-oncology-scoops-34m-for-ai-cancer-drug-prediction), [google.com](https://www.google.com/goto?url=CAESxQEBxCJF13ayQ_u0vbhPDtkwDfkOdo4p6_znvCcDPZsTZ9CeSXGM1a6lQodpPPpsZX88F98Tag0ysJUAgiguqxh5k20U3LymkT6WAEpAsXj5Kn6hK9d2npHbVWmtevWZKzcOmL2Sc5__XA12sYTfVg9GqHmA_XgQjxNmczpDKXL7Tt4Cdiln9mIEuXZbY0yZeul02zxLxE4iF7VjLkfdJjKk80wwjlZc8pyyZIdNckanZYUjMk8aZfWKxxRhCjmOwCW_MIDuPg&gsessionid=bEKy_OSYgPTMd-xoBQRspGRlni518LyvyUUTD2qjG25URjf50vB1_g) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.